Pinana, JL; Vazquez, L; Heras, I; Aiello, TF; López-Corral, L; Arroyo, I; Soler-Espejo, E; García-Cadenas, I; Garcia-Gutierrez, V; Aroca, C; Chorao, P; Olave, MT; Lopez-Jimenez, J; Gómez, MA; Arellano, E; Cuesta-Casas, M; Avendano-Pita, A; González-Santillana, C; Hernández-Rivas, JA; Roldán-Perez, A; Mico-Cerdá, M; Guerreiro, M; Morell, J; Rodriguez-Galvez, P; Labrador, J; Campos, D; Cedillo, A; Vidal, CG; Martino, R; Solano, C – 2024 – 10.3389/fonc.2024.1389345
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy – FRONTIERS IN ONCOLOGY
by prodriguez | Jan 1, 2024 | Publicaciones - BE-03 | 0 comments